BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 24, 2020
View Archived Issues
Enrollment ongoing in phase II study of LX-9211 in postherpetic neuralgia
Read More
CDI-45205 selected as lead compound for development against coronaviruses
Read More
11C-PABA for dynamic PET to evaluate renal function: preclinical and first-in-human results
Read More
Safety and efficacy of once-weekly insulin icodec compared with once-daily glargine in phase II
Read More
First patients dosed in phase I/II study of SIIPL's COVID-19 vaccine candidate plus CpG-1018
Read More
Intranasal RECCE-327 and RECCE-529 demonstrate activity against SARS-CoV-2 virus in vivo
Read More
Topline data from pivotal phase II/III VALO study of Qtorin rapamycin in pachyonychia congenita
Read More
Indian researchers divulge new compounds for tuberculosis
Read More
University of Minnesota discloses BET inhibitors
Read More
Beijing Tide Pharmaceutical synthesizes new ATR kinase inhibitors
Read More
Shaanxi Panlong Pharmaceutical presents compounds for leukemia
Read More
Verseau Therapeutics describes new anti-SIGLEC9 antibodies
Read More
FDA approves international phase III study of carrimycin in patients with severe COVID-19
Read More
Health Canada authorizes Moderna's COVID-19 vaccine
Read More
FDA issues clinical hold on IND application for AdCOVID
Read More
A2 Biotherapeutics and Merck collaborate to develop novel allogeneic cell therapy
Read More
Adipocyte telomere length controls susceptibility to diabetes
Read More
First-in-human data presented for AMG-701 in relapsed/refractory multiple myeloma
Read More
FDA issues a Study May Proceed letter for phase Ib trial of CX-5461
Read More
Abionyx launches phase IIa study of CER-001 for prevention of AKI in septic patients
Read More
